Info
| ID | 3017 |
| Metal | Ru |
| Oxidation state | 2 |
| Charge | 1 |
| Donor atoms | {"N": 6} |
| Abbreviation | Ru4 |
| SMILES | CCCCn1c(-c2[c-]ccc(-c3ccc(N(C)C)cc3)c2)nc2cc(C(=O)OC)ccc21.c1cnc2c(c1)c1nccnc1c1cccnc12.c1cnc2c(c1)c1nccnc1c1cccnc12 |
TUCAN
C55H44N11O2Ru/(1-53)(2-48)(3-49)(4-75)(5-75)(6-75)(7-76)(8-76)(9-98)(10-51)(11-59)(12-78)(13-52)(14-85)(15-85)(16-56)(17-63)(18-61)(19-54)(20-81)(21-47)(22-57)(23-79)(24-62)(25-77)(26-64)(27-98)(28-66)(29-65)(30-45)(31-45)(32-55)(33-50)(34-83)(35-58)(36-84)(37-80)(38-60)(39-76)(40-98)(41-82)(42-66)(43-65)(44-45)(45-66)(46-61)(46-72)(47-49)(47-67)(48-51)(48-78)(49-77)(50-60)(50-70)(51-68)(52-71)(52-91)(53-56)(53-94)(54-55)(54-96)(55-71)(56-73)(57-72)(57-74)(58-64)(58-73)(59-62)(59-82)(60-83)(61-63)(62-69)(63-74)(64-94)(65-66)(65-85)(67-86)(67-87)(68-88)(68-90)(69-92)(69-93)(70-89)(70-95)(71-99)(72-97)(73-74)(75-105)(76-105)(77-107)(78-101)(79-81)(79-100)(80-84)(80-102)(81-106)(82-103)(83-110)(84-109)(85-104)(86-90)(86-106)(87-88)(87-107)(88-101)(89-93)(89-110)(90-100)(91-96)(91-108)(92-95)(92-102)(93-103)(94-105)(95-109)(96-104)(97-104)(97-108)(98-112)(99-111)(99-112)(106-113)(107-113)(108-113)(109-113)(110-113)(112-113)
Measurements (3)
| Cell line | IC₅₀ dark (µM) | IC₅₀ light (µM) | DOI | Year |
| A375 | 0.7 | 0.36 | 10.1039/d4qi00732h | 2024 |
| HeLa | 1.2 | 0.5 | 10.1039/d4qi00732h | 2024 |
| OE33 | 3.2 | 1.8 | 10.1039/d4qi00732h | 2024 |
🧬 Cell Death Types (1)
Oncosis
high
«Thus, both early ATP depletion and porimin expression shown in these experiments support the oncosis as an overriding mechanism of a cell's death induced by Ru1 under irradiation.»
Source-assisted 2D generator
Builds the drawing from source ligand graphs and explicit donor metadata, then uses Metal2D only for layout. Publication output uses black bonds without arrows or colour highlighting; validated octahedral enantiomers are encoded directly with solid and hashed wedge bonds.
Loading source metadata…
The generated SVG will appear here. The legacy ligand image above stays visible for side-by-side review.